サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1786451

DNAおよびRNAバンキングサービスの世界市場

DNA & RNA Banking Services

出版日
ページ情報
英文 208 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.73円
DNAおよびRNAバンキングサービスの世界市場
出版日: 2025年08月08日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 208 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

DNAおよびRNAバンキングサービスの世界市場は2030年までに115億米ドルに達する

2024年に86億米ドルと推定されるDNAおよびRNAバンキングサービスの世界市場は、2024～2030年の分析期間にCAGR 4.9%で成長し、2030年には115億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである輸送サービスは、CAGR 3.8%を記録し、分析期間終了時には33億米ドルに達すると予測されます。加工サービス分野の成長率は、分析期間中CAGR 6.6%と推定されます。

米国市場は23億米ドルと推定・予測、中国はCAGR 4.8%で成長すると予測

米国のDNAおよびRNAバンキングサービス市場は、2024年には23億米ドルになると推定されます。世界第2位の経済大国である中国は、2030年までに18億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは4.8%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.2%と4.4%と予測されています。欧州では、ドイツがCAGR 4.1%で成長すると予測されています。

世界のDNAおよびRNAバンキングサービス市場- 主要動向と促進要因のまとめ

ゲノム調査の急増がDNAおよびRNAバンキングに革命をもたらす？

ゲノム研究の急成長と個別化医療における役割の拡大が、DNAおよびRNAバンキングサービスを世界的に急速に進化させる礎となっています。ゲノミクス、トランスクリプトミクス、ファーマコゲノミクスの分野がますます盛んになるにつれ、高品質で保存状態の良い核酸サンプルの需要が急増しています。創薬、疾患モデリング、バイオマーカー同定に携わる研究機関は、遺伝物質を安全に長期保存できるバイオバンクに大きく依存しています。DNAおよびRNAバンクサービスは、このように研究者、ヘルスケアプロバイダー、バイオテクノロジー企業にとって重要なサポートインフラとして台頭してきました。この急増は、がん、心血管疾患、神経変性疾患などの慢性疾患に対する遺伝的素因の特定に役立つ、集団規模のゲノム・データベースに対するニーズの高まりにも影響されています。政府も民間団体も同様に、多様な集団の遺伝情報を収集・分析するための大規模なバイオバンク事業に投資しています。これらのサービスでは、サンプルの収集、処理、保管、検索のための標準化されたプロトコルが提供され、研究結果の完全性と再現性が保証されています。さらに、COVID-19パンデミックは、迅速なゲノムサーベイランスの重要性を強調し、強固なRNA保存システムの必要性を浮き彫りにしました。その結果、バイオバンク施設は現在、スピード、安全性、拡張性への高まる期待に応えるため、高度な自動化、低温保存機能、デジタル在庫管理システムを備えた設計になっています。精密医療、人工知能、ゲノミクスの融合は、データ主導型ヘルスケアの限界を押し広げ続けており、DNAおよびRNAバンキングはバイオメディカル・イノベーション・エコシステムの中心的柱となっています。

進化するデータセキュリティ規範と倫理的配慮がサービスモデルを再構築する？

保存される遺伝物質の量と感度が高まるにつれて、データ・セキュリティ、倫理的ガバナンス、患者の同意をめぐる懸念も高まり、DNAおよびRNAバンキングサービスの運営方法が再構築されつつあります。遺伝子データは本質的に個人的で不変の性質を持っているため、プライバシー、所有権、誤用に関する重大な疑問が生じ、世界中の規制当局がコンプライアンスの枠組みを強化するよう促しています。欧州では一般データ保護規則（GDPR）、米国ではHIPAAといった法律が、遺伝物質の収集、保存、使用について厳格なガイドラインを課しており、サービスプロバイダーは強固なデータ暗号化、アクセス制御、トレーサビリティープロトコルを導入することを求められています。さらに、倫理的なバイオバンキングでは、参加者が自分のサンプルがどのように使用されるかを継続的に知らされ、特定の研究イニシアチブをオプトインまたはオプトアウトできるような、ダイナミックな同意モデルが要求されるようになっています。このような変化は、サンプルの出所を確実にし、不正アクセスから保護するために、ブロックチェーンベースのデータ管理システムやバイオメトリクス認証の採用を促しています。サービスプロバイダーはまた、サンプルのライフサイクル全体を通じて倫理基準を確実に組み込むために、スタッフトレーニングや施設審査委員会（IRB）との連携に投資しています。さらに、特に先住民や社会的地位の低い人々からサンプルを収集する場合、地域社会の関与と調査結果の透明性を求める傾向が高まっています。このような倫理的進化は、単なるコンプライアンスではなく、戦略的必須事項です。このような力学は、サービス提供モデルを変革するだけでなく、より広範な研究・診断サプライチェーンにおけるDNAおよびRNAバンキングサービスの戦略的価値を高めています。

商業化はバイオバンキングサービスの革新とアクセシビリティを促進するか？

DNAおよびRNAバンキング市場は、学術機関優位から、より商業的でサービス指向のモデルへと大きくシフトしつつあり、バイオバンキングをより身近でダイナミックなものにしています。歴史的には、バイオバンクは主に学術研究センターや政府機関に属していたが、遺伝子データに対する商業的関心の高まりにより、スケーラブルでオンデマンドの保管サービスを提供する非公開バイオバンク会社が出現した。これらのサービスは、製薬会社、CRO（医薬品開発業務受託機関）、不妊治療クリニック、さらにはDTC（消費者直接取引）遺伝子検査会社など、幅広い顧客向けに調整されるようになってきています。この商業化の波は、気相液体窒素システム、自動サンプル回収ロボット、統合ラボ情報管理システム（LIMS）などの最先端の保管技術への投資を促しています。さらに、バイオバンキングサービスは、核酸抽出、品質管理アッセイ、データ分析、さらにはサンプル物流管理などの付加価値ソリューションとバンドルされ、顧客にフルスペクトラムのサービス・エコシステムを提供しています。クラウドベースのサンプル追跡プラットフォームは、リアルタイムの在庫アクセスを可能にし、研究データベースや電子カルテ（EHR）との相互運用性は、臨床応用におけるサンプルの有用性を向上させています。国境を越えた共同研究や集中型バイオバンキングネットワークも支持を集めており、研究者は地理的・民族的に多様な遺伝子保存施設に物流上の障壁なしにアクセスできるようになっています。競合情勢はますますイノベーション主導型になりつつあり、市場各社はより迅速な納期、より高いサンプル品質保証、カスタマイズ可能なサービスモデルによって差別化を図っています。このシフトにより、高品質のバイオバンキングサービスへのアクセスが民主化され、小規模ラボや新興企業でも、独自の保管インフラに投資することなく、最先端のゲノム研究に参加できるようになっています。

DNAおよびRNAバンキングサービス市場を支える真の成長触媒とは？

DNAおよびRNAバンキングサービス市場の成長は、科学の進歩、進化するエンドユーザー・ニーズ、技術インフラに基づくいくつかの要因によって牽引されています。とりわけ、学術、臨床、商業の各分野におけるゲノムおよびトランスクリプトーム研究の急増は、核酸の安全かつスケーラブルな保管に対する一貫した需要を生み出しています。この需要は、次世代シーケンシング（NGS）や、長期保存を必要とする膨大な量の遺伝物質を生成するその他のハイスループット分子生物学技術の広範な採用によって拡大されています。さらに、製薬会社やバイオテクノロジー企業は、これらのサービスを活用して、標的薬剤開発や個別化治療アプローチをサポートする包括的な遺伝子データセットを構築しています。もう一つの重要な推進力は、集団全体の遺伝的多様性と健康パターンを解読することを目的とした大規模疫学研究や国家ゲノム構想において、バイオバンク・サンプルへの依存度が高まっていることです。さらに、mRNAワクチン開発やトランスクリプトーム・プロファイリングなど、RNAベースのアプリケーションの利用が拡大していることから、RNAの完全性を厳密に保持する超低温保存システムの必要性が浮き彫りになっています。消費者行動の変化も一役買っています。家庭用遺伝子検査キットの人気は、安全で長期保存が可能なオプションを必要とする消費者生成サンプルの急増につながり、バイオバンクサービスに新たな道を開いた。技術レベルでは、AIと機械学習がバイオバンクのデータ管理に統合されることで、予測分析とよりスマートな資源配分が可能になりつつあります。最後に、公衆衛生機関、民間サービスプロバイダー、学術機関の間の戦略的協力関係により、標準化された業務が促進され、保存された遺伝物質への世界のアクセシビリティが広がっています。これらの促進要因が相まって、DNAおよびRNAバンキングサービスの市場は回復力があり急速に拡大しており、次世代のヘルスケアと生物医学の革新に不可欠なものとなっています。

セグメント

サービス（輸送サービス、処理サービス、保管サービス、品質管理サービス、データ保管、その他サービス）、検体（血液、口腔スワブ・毛包、その他）、用途（治療、創薬・臨床研究、臨床診断、その他用途）、最終用途（学術研究、製薬・バイオ企業、病院・診断センター、その他）

調査対象企業の例

  • 23andMe, Inc.
  • AstridBio Ltd.
  • Biomatrica, Inc.
  • Brooks Life Sciences
  • Coriell Institute for Medical Research
  • deCODE genetics
  • DNA Genotek Inc.
  • EasyDNA
  • Genetic Services of America
  • GenVault Corporation
  • GoodCell
  • Infinity Biologix
  • LGC Biosearch Technologies
  • MedGenome Inc.
  • National Center for Biotechnology Information（NCBI）
  • PreventionGenetics
  • ProteoGenex
  • Qiagen N.V.
  • Sampled（formerly RUCDR Infinite Biologics）
  • Thermo Fisher Scientific, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP30554

Global DNA & RNA Banking Services Market to Reach US$11.5 Billion by 2030

The global market for DNA & RNA Banking Services estimated at US$8.6 Billion in the year 2024, is expected to reach US$11.5 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. Transportation Service, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$3.3 Billion by the end of the analysis period. Growth in the Processing Service segment is estimated at 6.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 4.8% CAGR

The DNA & RNA Banking Services market in the U.S. is estimated at US$2.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global DNA & RNA Banking Services Market - Key Trends & Drivers Summarized

Is the Surge in Genomic Research Revolutionizing the DNA & RNA Banking Landscape?

The exponential growth in genomic research and its expanding role in personalized medicine have become the cornerstone driving the rapid evolution of DNA and RNA banking services globally. As the fields of genomics, transcriptomics, and pharmacogenomics continue to flourish, the demand for high-quality, well-preserved nucleic acid samples has surged. Institutions involved in drug discovery, disease modeling, and biomarker identification rely heavily on biobanks that offer secure, long-term storage of genetic material. DNA and RNA banking services have thus emerged as a critical support infrastructure for researchers, healthcare providers, and biotechnology firms. This surge is also influenced by the increasing need for population-scale genomic databases that help identify genetic predispositions to chronic diseases such as cancer, cardiovascular disorders, and neurodegenerative conditions. Governments and private organizations alike are investing in large-scale biobanking initiatives to collect and analyze genetic information across diverse populations. These services provide standardized protocols for sample collection, processing, storage, and retrieval-ensuring the integrity and reproducibility of research findings. Additionally, the COVID-19 pandemic underscored the importance of rapid genomic surveillance and highlighted the need for robust RNA preservation systems, further emphasizing the critical role these services play. As a result, biobanking facilities are now being designed with advanced automation, cryogenic storage capabilities, and digital inventory management systems to meet the rising expectations for speed, security, and scalability. The convergence of precision medicine, artificial intelligence, and genomics continues to push the boundaries of data-driven healthcare, making DNA and RNA banking a central pillar in the biomedical innovation ecosystem.

Are Evolving Data Security Norms and Ethical Considerations Reshaping Service Models?

As the volume and sensitivity of stored genetic material increase, so do concerns around data security, ethical governance, and patient consent-factors that are reshaping how DNA and RNA banking services operate. The inherently personal and immutable nature of genetic data raises significant questions about privacy, ownership, and misuse, prompting regulatory authorities worldwide to strengthen compliance frameworks. Legislation such as the General Data Protection Regulation (GDPR) in Europe and HIPAA in the U.S. impose strict guidelines on the collection, storage, and usage of genetic material, requiring service providers to implement robust data encryption, access controls, and traceability protocols. Moreover, ethical biobanking now demands dynamic consent models, where participants are continually informed about how their samples are being used, and can opt in or out of specific research initiatives. These changes are encouraging the adoption of blockchain-based data management systems and biometric authentication to ensure sample provenance and protect against unauthorized access. Service providers are also investing in staff training and institutional review board (IRB) collaborations to ensure that ethical standards are embedded throughout the sample life cycle. Additionally, there's a rising trend toward community engagement and transparency in research outcomes, especially when collecting samples from indigenous or underrepresented populations. This ethical evolution is not merely a compliance exercise but a strategic imperative-institutions that prioritize ethical integrity and data security are increasingly viewed as more credible and desirable partners for international research collaborations and funding opportunities. These dynamics are not only transforming service delivery models but are also elevating the strategic value of DNA and RNA banking services in the broader research and diagnostics supply chain.

Is Commercialization Driving Innovation and Accessibility in Biobanking Services?

The DNA and RNA banking market is undergoing a profound shift from academic and institutional dominance toward a more commercial, service-oriented model that is making biobanking more accessible and dynamic. Historically, biobanks were primarily affiliated with academic research centers and government institutions, but the growing commercial interest in genetic data has led to the emergence of private biobanking companies offering scalable and on-demand storage services. These services are increasingly tailored for a broad array of clients-including pharmaceutical companies, contract research organizations (CROs), fertility clinics, and even direct-to-consumer (DTC) genetic testing firms. This commercialization wave is driving investments into state-of-the-art storage technologies such as vapor-phase liquid nitrogen systems, automated sample retrieval robotics, and integrated laboratory information management systems (LIMS). Moreover, biobanking services are being bundled with value-added solutions like nucleic acid extraction, quality control assays, data analytics, and even sample logistics management, offering a full-spectrum service ecosystem to clients. Cloud-based sample tracking platforms now enable real-time inventory access, while interoperability with research databases and electronic health records (EHRs) is improving sample utility in clinical applications. Cross-border collaborations and centralized biobanking networks are also gaining traction, allowing researchers to access geographically and ethnically diverse genetic repositories without logistical barriers. The competitive landscape is becoming increasingly innovation-driven, with market players differentiating through faster turnaround times, higher sample quality assurance, and customizable service models. This shift is democratizing access to high-quality biobanking services, enabling even small labs and startups to participate in cutting-edge genomic research without having to invest in their own storage infrastructure.

What Are the True Growth Catalysts Behind the DNA & RNA Banking Services Market?

The growth in the DNA and RNA banking services market is driven by several factors grounded in scientific advancements, evolving end-user needs, and technological infrastructure. Foremost, the surge in genomic and transcriptomic research across academic, clinical, and commercial settings is creating consistent demand for secure and scalable storage of nucleic acids. This demand is magnified by the widespread adoption of next-generation sequencing (NGS) and other high-throughput molecular biology techniques that generate vast volumes of genetic material requiring long-term preservation. Additionally, pharmaceutical and biotech companies are leveraging these services to build comprehensive genetic datasets that support targeted drug development and personalized therapy approaches. Another crucial driver is the increasing reliance on biobanked samples in large-scale epidemiological studies and national genome initiatives that aim to decode genetic diversity and health patterns across populations. Furthermore, the growing use of RNA-based applications-such as mRNA vaccine development and transcriptomic profiling-has underscored the need for ultra-low temperature storage systems with strict RNA integrity preservation. Changing consumer behavior is also playing a role; the popularity of at-home genetic testing kits has led to a proliferation of consumer-generated samples requiring safe, long-term storage options, which has opened new avenues for biobanking services. At the technological level, the integration of AI and machine learning into biobank data management is enabling predictive analytics and smarter resource allocation. Finally, strategic collaborations between public health organizations, private service providers, and academic institutions are fostering standardized practices and broader global accessibility to stored genetic materials. These converging drivers are collectively shaping a resilient and fast-expanding market for DNA and RNA banking services, positioning it as a critical enabler of the next generation of healthcare and biomedical innovation.

SCOPE OF STUDY:

The report analyzes the DNA & RNA Banking Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service (Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage, Other Services); Specimen (Blood Specimen, Buccal Swabs & Hair Follicles Specimen, Other Specimens); Application (Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application, Other Applications); End-Use (Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 34 Featured) -

  • 23andMe, Inc.
  • AstridBio Ltd.
  • Biomatrica, Inc.
  • Brooks Life Sciences
  • Coriell Institute for Medical Research
  • deCODE genetics
  • DNA Genotek Inc.
  • EasyDNA
  • Genetic Services of America
  • GenVault Corporation
  • GoodCell
  • Infinity Biologix
  • LGC Biosearch Technologies
  • MedGenome Inc.
  • National Center for Biotechnology Information (NCBI)
  • PreventionGenetics
  • ProteoGenex
  • Qiagen N.V.
  • Sampled (formerly RUCDR Infinite Biologics)
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • DNA & RNA Banking Services - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Focus on Genomic and Precision Medicine Throws the Spotlight on DNA & RNA Biobanking Needs
    • Surge in Population-Scale Genomic Initiatives Propels Growth in Long-Term Nucleic Acid Storage Demand
    • Integration of AI and Big Data Analytics Strengthens Business Case for Digitalized Biobanking Systems
    • Increasing Demand for High-Quality Biospecimens in Drug Discovery Expands Addressable Market Opportunity
    • Widespread Adoption of Personalized Therapies Drives Adoption of Patient-Centric DNA & RNA Sample Repositories
    • Growing Role of Biobanks in Translational Research Accelerates Demand for Multi-Omics Sample Storage Infrastructure
    • Expansion of Clinical Trials and Biomarker Research Spurs Use of DNA & RNA Banking Across Pharma Pipelines
    • Advancements in Cryopreservation and Sample Handling Technologies Enhance Reliability and Long-Term Storage Viability
    • Growing Emphasis on Ethical Consent and Data Governance Strengthens Compliance-Driven Biobanking Models
    • Rise in Infectious Disease Surveillance and Pandemic Preparedness Generates Demand for RNA Sample Archiving
    • Outsourcing Trends Among CROs and Academic Institutions Sustain Growth of Commercial Biobanking Services
    • Demand for Standardized Protocols and Global Interoperability Drives Industry-Wide Harmonization Efforts
    • Shift Toward Integrated Biobank Networks and Cloud-Linked Repositories Expands Scalability and Access
    • Use of Blockchain and Secure Access Tools Enhances Trust and Transparency in Genomic Data Storage Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World DNA & RNA Banking Services Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for DNA & RNA Banking Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Transportation Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Transportation Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Processing Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Processing Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Storage Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Storage Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Quality Control Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Quality Control Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Data Storage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Data Storage by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Therapeutics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Therapeutics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Drug Discovery & Clinical Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Drug Discovery & Clinical Research Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Clinical Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Clinical Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Academic Research End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Academic Research End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Hospitals & Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Blood Specimen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for Blood Specimen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Buccal Swabs & Hair Follicles Specimen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 35: World 6-Year Perspective for Buccal Swabs & Hair Follicles Specimen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 36: World Recent Past, Current & Future Analysis for Other Specimens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 37: World 6-Year Perspective for Other Specimens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • DNA & RNA Banking Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Service - Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for DNA & RNA Banking Services by Service - Percentage Breakdown of Value Sales for Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services for the Years 2025 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Application - Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: USA 6-Year Perspective for DNA & RNA Banking Services by Application - Percentage Breakdown of Value Sales for Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications for the Years 2025 & 2030
    • TABLE 42: USA Recent Past, Current & Future Analysis for DNA & RNA Banking Services by End-Use - Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: USA 6-Year Perspective for DNA & RNA Banking Services by End-Use - Percentage Breakdown of Value Sales for Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Specimen - Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA 6-Year Perspective for DNA & RNA Banking Services by Specimen - Percentage Breakdown of Value Sales for Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens for the Years 2025 & 2030
  • CANADA
    • TABLE 46: Canada Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Service - Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for DNA & RNA Banking Services by Service - Percentage Breakdown of Value Sales for Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Application - Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for DNA & RNA Banking Services by Application - Percentage Breakdown of Value Sales for Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications for the Years 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for DNA & RNA Banking Services by End-Use - Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada 6-Year Perspective for DNA & RNA Banking Services by End-Use - Percentage Breakdown of Value Sales for Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 52: Canada Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Specimen - Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Canada 6-Year Perspective for DNA & RNA Banking Services by Specimen - Percentage Breakdown of Value Sales for Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens for the Years 2025 & 2030
  • JAPAN
    • DNA & RNA Banking Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 54: Japan Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Service - Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for DNA & RNA Banking Services by Service - Percentage Breakdown of Value Sales for Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Application - Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for DNA & RNA Banking Services by Application - Percentage Breakdown of Value Sales for Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications for the Years 2025 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for DNA & RNA Banking Services by End-Use - Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Japan 6-Year Perspective for DNA & RNA Banking Services by End-Use - Percentage Breakdown of Value Sales for Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 60: Japan Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Specimen - Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Japan 6-Year Perspective for DNA & RNA Banking Services by Specimen - Percentage Breakdown of Value Sales for Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens for the Years 2025 & 2030
  • CHINA
    • DNA & RNA Banking Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Service - Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for DNA & RNA Banking Services by Service - Percentage Breakdown of Value Sales for Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services for the Years 2025 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Application - Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for DNA & RNA Banking Services by Application - Percentage Breakdown of Value Sales for Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications for the Years 2025 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for DNA & RNA Banking Services by End-Use - Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: China 6-Year Perspective for DNA & RNA Banking Services by End-Use - Percentage Breakdown of Value Sales for Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Specimen - Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China 6-Year Perspective for DNA & RNA Banking Services by Specimen - Percentage Breakdown of Value Sales for Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens for the Years 2025 & 2030
  • EUROPE
    • DNA & RNA Banking Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 70: Europe Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for DNA & RNA Banking Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Service - Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for DNA & RNA Banking Services by Service - Percentage Breakdown of Value Sales for Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services for the Years 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Application - Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for DNA & RNA Banking Services by Application - Percentage Breakdown of Value Sales for Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications for the Years 2025 & 2030
    • TABLE 76: Europe Recent Past, Current & Future Analysis for DNA & RNA Banking Services by End-Use - Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Europe 6-Year Perspective for DNA & RNA Banking Services by End-Use - Percentage Breakdown of Value Sales for Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 78: Europe Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Specimen - Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Europe 6-Year Perspective for DNA & RNA Banking Services by Specimen - Percentage Breakdown of Value Sales for Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens for the Years 2025 & 2030
  • FRANCE
    • DNA & RNA Banking Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Service - Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France 6-Year Perspective for DNA & RNA Banking Services by Service - Percentage Breakdown of Value Sales for Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services for the Years 2025 & 2030
    • TABLE 82: France Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Application - Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: France 6-Year Perspective for DNA & RNA Banking Services by Application - Percentage Breakdown of Value Sales for Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications for the Years 2025 & 2030
    • TABLE 84: France Recent Past, Current & Future Analysis for DNA & RNA Banking Services by End-Use - Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: France 6-Year Perspective for DNA & RNA Banking Services by End-Use - Percentage Breakdown of Value Sales for Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Specimen - Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France 6-Year Perspective for DNA & RNA Banking Services by Specimen - Percentage Breakdown of Value Sales for Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens for the Years 2025 & 2030
  • GERMANY
    • DNA & RNA Banking Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 88: Germany Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Service - Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Germany 6-Year Perspective for DNA & RNA Banking Services by Service - Percentage Breakdown of Value Sales for Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services for the Years 2025 & 2030
    • TABLE 90: Germany Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Application - Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Germany 6-Year Perspective for DNA & RNA Banking Services by Application - Percentage Breakdown of Value Sales for Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications for the Years 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for DNA & RNA Banking Services by End-Use - Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany 6-Year Perspective for DNA & RNA Banking Services by End-Use - Percentage Breakdown of Value Sales for Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 94: Germany Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Specimen - Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Germany 6-Year Perspective for DNA & RNA Banking Services by Specimen - Percentage Breakdown of Value Sales for Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens for the Years 2025 & 2030
  • ITALY
    • TABLE 96: Italy Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Service - Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Italy 6-Year Perspective for DNA & RNA Banking Services by Service - Percentage Breakdown of Value Sales for Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services for the Years 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Application - Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy 6-Year Perspective for DNA & RNA Banking Services by Application - Percentage Breakdown of Value Sales for Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications for the Years 2025 & 2030
    • TABLE 100: Italy Recent Past, Current & Future Analysis for DNA & RNA Banking Services by End-Use - Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Italy 6-Year Perspective for DNA & RNA Banking Services by End-Use - Percentage Breakdown of Value Sales for Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 102: Italy Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Specimen - Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Italy 6-Year Perspective for DNA & RNA Banking Services by Specimen - Percentage Breakdown of Value Sales for Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens for the Years 2025 & 2030
  • UNITED KINGDOM
    • DNA & RNA Banking Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Service - Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK 6-Year Perspective for DNA & RNA Banking Services by Service - Percentage Breakdown of Value Sales for Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services for the Years 2025 & 2030
    • TABLE 106: UK Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Application - Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 107: UK 6-Year Perspective for DNA & RNA Banking Services by Application - Percentage Breakdown of Value Sales for Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications for the Years 2025 & 2030
    • TABLE 108: UK Recent Past, Current & Future Analysis for DNA & RNA Banking Services by End-Use - Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 109: UK 6-Year Perspective for DNA & RNA Banking Services by End-Use - Percentage Breakdown of Value Sales for Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Specimen - Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK 6-Year Perspective for DNA & RNA Banking Services by Specimen - Percentage Breakdown of Value Sales for Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Service - Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Rest of Europe 6-Year Perspective for DNA & RNA Banking Services by Service - Percentage Breakdown of Value Sales for Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services for the Years 2025 & 2030
    • TABLE 114: Rest of Europe Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Application - Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Rest of Europe 6-Year Perspective for DNA & RNA Banking Services by Application - Percentage Breakdown of Value Sales for Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications for the Years 2025 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for DNA & RNA Banking Services by End-Use - Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe 6-Year Perspective for DNA & RNA Banking Services by End-Use - Percentage Breakdown of Value Sales for Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 118: Rest of Europe Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Specimen - Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Rest of Europe 6-Year Perspective for DNA & RNA Banking Services by Specimen - Percentage Breakdown of Value Sales for Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens for the Years 2025 & 2030
  • ASIA-PACIFIC
    • DNA & RNA Banking Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Service - Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Asia-Pacific 6-Year Perspective for DNA & RNA Banking Services by Service - Percentage Breakdown of Value Sales for Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services for the Years 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Application - Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific 6-Year Perspective for DNA & RNA Banking Services by Application - Percentage Breakdown of Value Sales for Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications for the Years 2025 & 2030
    • TABLE 124: Asia-Pacific Recent Past, Current & Future Analysis for DNA & RNA Banking Services by End-Use - Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Asia-Pacific 6-Year Perspective for DNA & RNA Banking Services by End-Use - Percentage Breakdown of Value Sales for Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 126: Asia-Pacific Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Specimen - Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Asia-Pacific 6-Year Perspective for DNA & RNA Banking Services by Specimen - Percentage Breakdown of Value Sales for Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Service - Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of World 6-Year Perspective for DNA & RNA Banking Services by Service - Percentage Breakdown of Value Sales for Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services for the Years 2025 & 2030
    • TABLE 130: Rest of World Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Application - Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of World 6-Year Perspective for DNA & RNA Banking Services by Application - Percentage Breakdown of Value Sales for Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications for the Years 2025 & 2030
    • TABLE 132: Rest of World Recent Past, Current & Future Analysis for DNA & RNA Banking Services by End-Use - Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Rest of World 6-Year Perspective for DNA & RNA Banking Services by End-Use - Percentage Breakdown of Value Sales for Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Specimen - Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of World 6-Year Perspective for DNA & RNA Banking Services by Specimen - Percentage Breakdown of Value Sales for Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens for the Years 2025 & 2030

IV. COMPETITION